Future studies are warranted to investigate whether EZH2 might regulate ferroptosis via the GPX4 pathway in mucosal melanoma, further broadening the therapeutic potential of targeting EZH2 in ferroptosis-related cancer treatments. The gene discussed is GPX4; the disease is cancer.